31 agosto 2015
Fatal bleeding is rare with extended dual antiplatelet therapy, according to a secondary analysis of the DAPT Study. Bleeding-related mortality accounted for a minority of deaths in patients treated with dual antiplatelet therapy beyond one year.
http://www.sciencedaily.com/releases/2015/08/150831101835.htm
